Introduction
Progressive familial intrahepatic cholestasis (PFIC), known as a group of heterogeneous autosomal recessive disorders, hit liver hepatocellular bile salt secretion as a cholestasis of hepatocellular origin appearing in infants and leading to death from liver failure. Three types of PFIC have been defined from the hepatocellular transport system defects and related genes, which involved in bile formation. [1] [2] [3] Main clinical manifestations include cholestasis, pruritus and jaundice. These patients usually develop fibrosis and end-stage liver disease before adulthood. [4] PFIC type 1 is caused by mutations in ATP8B1 (chromosome 18q21), which encodes FIC1 protein. PFIC type 2 is identified by mutations in ABCB11 (chromosome 2q24), which encodes bile salt export pump (BSEP) and defects in ABCB4-encoding the multi-drug resistant 3 (MDR3) protein -impair biliary phospholipid secretion cause PFIC3. Both PFIC1 and PFIC2 are caused by impaired bile salt secretion appearing in first months of life but PFIC3 is caused by impaired biliary phospholipid secretion and may manifest later. [1, 2] 
Case Report

Pathological study
The diagnosis of the kind of PFIC can be difficult and giant cell transformation. [1, 2] Immune staining is a useful diagnostic tool for PFIC type 2 since most patients with ABCB11 mutations and hepatobiliary disease of onset in infancy have no canalicular BSEP expression. [5] So pathological study was performed on proband. Hepatocellular swelling with multinucleated canalicular and hepatocellular cholestasis, portal lymphocytic infiltration and fibrosis, newly formed liver nodules, bridging necrosis, bile duct proliferation, giant cells and micro vesicular fat droplet can be seen in proband liver biopsy [ Figure 1 ].
Mutation Analysis
Mutation analysis was performed on DNA of the patient and both parents. The genomic DNA was extracted from peripheral blood leukocytes and ABCB11 of all 27 coding exons and intron/exon borders were screened by intronic oligonucleotide primers as reported previously [6] and direct sequencing of PCR products. A novel homozygous mutation 3593-A > G was detected in exon 25 [ Figure 2 ]. This mutation leads to the missense mutation (His1198Arg). There is a small physicochemical difference between His and Arg, but the amino acid histidine at codon 1198 is highly conserved between species (up till C. elegans) and isoforms (ABCB 1, 4, 5, 6, 7, 8, 9, 11) . PolyPhen predicts a probably damaging effect (PSIC score difference: 3.349) and SIFT also predicts that this substitution could affect protein function.
Parents were heterozygote for this mutation.
Discussion
To the best of our knowledge, this is the first case bile duct damage were observed. In PFIC type 2, the liver histology shows more inflammatory activity than in PFIC type 1 with giant cell transformation and lobular and portal fibrosis. To date, more than 100 mutation in ABCB11 gene have been identified. [5, 7, 8] Severe phenotypes are often associated with mutations that lead to premature protein truncation or failure of protein production. Insertion, deletion, nonsense, and splicing mutations result in damaging effects, and patients who have clinical PFIC associated with such mutations exhibit little or no BSEP expression in hepatocyte canaliculi. [2, 5] In Asian patients, few reports of mutations in PFIC type 2 exist [9, 10] Goto et al. [8] have reported four mutations in ABCB11 gene, predicated to yield V330X, R487H, R575X and E636G in two Japanese PFIC patients. Chen et al. [10] have reported seven BSEP mutations (M183V, V284L, R303K, R487H, W493X, G1004D and 1145delC) in four PFIC patients of Chinese descent; none of these mutations has been described in Caucasian patients. But here we found a new mutation in ABCB11 gene. This mutation is a novel homozygous mutation that leads to the missense mutation (His1198Arg).
